Salmonella Typhi whole genome sequencing in Rwanda shows a diverse historical population with recent introduction of haplotype H58

Copyright: © 2023 Rutanga et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited..

Salmonella enterica serovar Typhi (S. Typhi) is the cause of typhoid fever, presenting high rates of morbidity and mortality in low- and middle-income countries. The H58 haplotype shows high levels of antimicrobial resistance (AMR) and is the dominant S. Typhi haplotype in endemic areas of Asia and East sub-Saharan Africa. The situation in Rwanda is currently unknown and therefore to reveal the genetic diversity and AMR of S. Typhi in Rwanda, 25 historical (1984-1985) and 26 recent (2010-2018) isolates from Rwanda were analysed using whole genome sequencing (WGS). WGS was locally implemented using Illumina MiniSeq and web-based analysis tools, thereafter complemented with bioinformatic approaches for more in-depth analyses. Whereas historical S. Typhi isolates were found to be fully susceptible to antimicrobials and show a diversity of genotypes, i.e 2.2.2, 2.5, 3.3.1 and 4.1; the recent isolates showed high AMR rates and were predominantly associated with genotype 4.3.1.2 (H58, 22/26; 84,6%), possibly resulting from a single introduction in Rwanda from South Asia before 2010. We identified practical challenges for the use of WGS in endemic regions, including a high cost for shipment of molecular reagents and lack of high-end computational infrastructure for the analyses, but also identified WGS to be feasible in the studied setting and giving opportunity for synergy with other programs.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

PLoS neglected tropical diseases - 17(2023), 6 vom: 04. Juni, Seite e0011285

Sprache:

Englisch

Beteiligte Personen:

Rutanga, Jean Pierre [VerfasserIn]
de Block, Tessa [VerfasserIn]
Cuypers, Wim L [VerfasserIn]
Cafmeyer, Josephine [VerfasserIn]
Peeters, Marjan [VerfasserIn]
Umumararungu, Esperance [VerfasserIn]
Ngabonziza, Jean Claude S [VerfasserIn]
Rucogoza, Aniceth [VerfasserIn]
Vandenberg, Olivier [VerfasserIn]
Martiny, Delphine [VerfasserIn]
Dusabe, Angélique [VerfasserIn]
Nkubana, Théoneste [VerfasserIn]
Dougan, Gordon [VerfasserIn]
Muvunyi, Claude Mambo [VerfasserIn]
Mwikarago, Ivan Emil [VerfasserIn]
Jacobs, Jan [VerfasserIn]
Deborggraeve, Stijn [VerfasserIn]
Van Puyvelde, Sandra [VerfasserIn]

Links:

Volltext

Themen:

Anti-Bacterial Agents
Journal Article

Anmerkungen:

Date Completed 03.07.2023

Date Revised 16.11.2023

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pntd.0011285

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM35828791X